Accelerating drug discovery and functional formulation for Argentine pharmaceutical innovators through precision botanical metabolite isolation, in vitro testing, and validated analytical pipelines.
Argentina represents one of Latin America's most dynamic landscapes for biotechnology, phytotherapeutics, and high-titer natural supplements. Balancing vast indigenous biodiversity with stringent regulatory governance demands world-class analytical rigor.
Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT) imposes stringent guidelines under Disposición 2673/99 and updated phytomedicine directives. Natural pharmaceutical formulations require unambiguous phytochemical fingerprinting, heavy metal thresholds, residual solvent elimination, and reproducible batch efficacy that generic testing laboratories often fail to provide.
The Argentine industrial sector is actively pivoting toward extracting value from native botanical assets—ranging from Ilex paraguariensis (Yerba Mate) xanthines and polyphenols to Andean medicinal herbs (Jarilla, Peperina). OEM screening pipelines isolate high-value bioactive fractions for cardiovascular, metabolic, and dermo-cosmetic patent filings.
Facing domestic capital expenditure constraints and high costs of imported analytical instrumentation (UPLC-Q-TOF-MS, NMR), Argentine laboratory hubs in Buenos Aires, Córdoba, and Rosario partner with established Chinese CRO/CDMO operators to offshore complex screening and scale-up while retaining intellectual property rights.
Combining the vast industrial scale and technological depth of China’s natural medicine supply chain with seamless logistical coordination for Latin American trade channels.
Traditional screening CROs stop at data generation, leaving clients with the burden of tech-transferring protocols to commercial extractors. MedGence bridges this gap: our pilot facilities and commercial factories transfer HPLC/HPTLC analytical assays directly into metric-ton batch production under ISO 9001, cGMP, and HACCP compliance.
We provide comprehensive analytical packages—including chromatographic fingerprinting, quantitative multi-compound assays, accelerated stability testing (Zone IVb climatic conditions), and impurity profiles—tailored specifically to satisfy Argentine ANMAT and wider Mercosur import dossiers.
By leveraging standardized botanical raw material databases, extensive compound libraries, and high-throughput automated robotic screening platforms in Changsha, we reduce compound discovery timelines from years to months, allowing Argentine innovators to capture first-mover market advantages.
Proprietary botanical formulations and client-entrusted fractionation protocols remain protected under stringent cross-border non-disclosure agreements. We operate on a pure contract research and manufacturing basis, ensuring your intellectual property remains exclusively yours.
A rigorous, peer-reviewed six-stage protocol transforming crude biomass into validated, clinical-grade active ingredients.
Assessment of geographical origins, seasonal potency variations, and specific botanical anatomical parts (roots, leaves, bark) to maximize target active yield.
Optimizing extraction kinetics using eco-friendly solvents, subcritical water, or supercritical CO2 to isolate sensitive flavonoids, polyphenols, and alkaloids without degradation.
Developing validated quantitative and qualitative chromatographic methods that unambiguously identify marker compounds for regulatory scrutiny.
Screening bioactivity against cell-line panels (anti-inflammatory, antioxidant, metabolic enzyme inhibition) alongside LD50, acute, chronic, and Ames genotoxicity tests.
Validating industrial reproducibility, spray-drying, microencapsulation, and crystallization parameters to prevent thermal degradation during commercial manufacturing.
Exporting high-purity active powder, liquid extracts, or finished dosage formulations backed by complete Certificates of Analysis (COA) for rapid Argentine customs clearance.
Essential insights for procurement managers, regulatory directors, and R&D executives evaluating overseas CRO/CDMO partnerships.
Explore our complete spectrum of active screening, analytical validation, preclinical studies, and commercial clinical development packages serving Latin American partners.
Connect directly with our lead phytochemical scientists and international trade team. Gain instant access to study feasibility assessments, quotation matrices, and sample screening protocols tailored to the Argentine regulatory framework.